These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 8472903

  • 1. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
    Cahill ES, O'Hagan DT, Illum L, Redhead K.
    FEMS Microbiol Lett; 1993 Mar 01; 107(2-3):211-6. PubMed ID: 8472903
    [Abstract] [Full Text] [Related]

  • 2. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles.
    Cahill ES, O'Hagan DT, Illum L, Barnard A, Mills KH, Redhead K.
    Vaccine; 1995 Apr 01; 13(5):455-62. PubMed ID: 7639014
    [Abstract] [Full Text] [Related]

  • 3. Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA.
    Roberts M, Cropley I, Chatfield S, Dougan G.
    Vaccine; 1993 Apr 01; 11(8):866-72. PubMed ID: 8356847
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
    Knight JB, Huang YY, Halperin SA, Anderson R, Morris A, Macmillan A, Jones T, Burt DS, Van Nest G, Lee SF.
    Clin Exp Immunol; 2006 Jun 01; 144(3):543-51. PubMed ID: 16734625
    [Abstract] [Full Text] [Related]

  • 5. Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells.
    Conway MA, Madrigal-Estebas L, McClean S, Brayden DJ, Mills KH.
    Vaccine; 2001 Feb 28; 19(15-16):1940-50. PubMed ID: 11228364
    [Abstract] [Full Text] [Related]

  • 6. Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.
    Kimura A, Mountzouros KT, Relman DA, Falkow S, Cowell JL.
    Infect Immun; 1990 Jan 28; 58(1):7-16. PubMed ID: 2294058
    [Abstract] [Full Text] [Related]

  • 7. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M, Yasuda Y, Taniguchi T, Kozuka S, Matano K, Maeyama J, Morokuma K, Ohkuma K, Goto N, Tochikubo K.
    Vaccine; 2003 Mar 07; 21(11-12):1165-73. PubMed ID: 12559794
    [Abstract] [Full Text] [Related]

  • 8. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
    Watanabe M, Nagai M.
    Infect Immun; 2001 Nov 07; 69(11):6981-6. PubMed ID: 11598073
    [Abstract] [Full Text] [Related]

  • 9. Eighty-kilodalton N-terminal moiety of Bordetella pertussis filamentous hemagglutinin: adherence, immunogenicity, and protective role.
    Alonso S, Reveneau N, Pethe K, Locht C.
    Infect Immun; 2002 Aug 07; 70(8):4142-7. PubMed ID: 12117922
    [Abstract] [Full Text] [Related]

  • 10. Genital antibody responses in mice after intranasal infection with an attenuated candidate vector strain of Bordetella pertussis.
    Mielcarek N, Nordström I, Menozzi FD, Locht C, Holmgren J.
    Infect Immun; 2000 Feb 07; 68(2):485-91. PubMed ID: 10639408
    [Abstract] [Full Text] [Related]

  • 11. Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection.
    Shahin RD, Amsbaugh DF, Leef MF.
    Infect Immun; 1992 Apr 07; 60(4):1482-8. PubMed ID: 1548072
    [Abstract] [Full Text] [Related]

  • 12. Serological correlates in whooping cough.
    Granström M, Granström G.
    Vaccine; 1993 Apr 07; 11(4):445-8. PubMed ID: 8470429
    [Abstract] [Full Text] [Related]

  • 13. Serological responses to infection with B. pertussis.
    Giammanco A, Taormina S, Genovese M, Mangiaracina G, Giammanco G, Chiarini A.
    Dev Biol Stand; 1997 Apr 07; 89():213-20. PubMed ID: 9272353
    [Abstract] [Full Text] [Related]

  • 14. A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteers.
    Berstad AKH, Holst J, Frøholm LO, Haugen IL, Wedege E, Oftung F, Haneberg B.
    J Med Microbiol; 2000 Feb 07; 49(2):157-163. PubMed ID: 10670566
    [Abstract] [Full Text] [Related]

  • 15. Long-lived respiratory immune response to filamentous hemagglutinin following Bordetella pertussis infection.
    Amsbaugh DF, Li ZM, Shahin RD.
    Infect Immun; 1993 Apr 07; 61(4):1447-52. PubMed ID: 8454349
    [Abstract] [Full Text] [Related]

  • 16. Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis.
    Renauld-Mongénie G, Mielcarek N, Cornette J, Schacht AM, Capron A, Riveau G, Locht C.
    Proc Natl Acad Sci U S A; 1996 Jul 23; 93(15):7944-9. PubMed ID: 8755582
    [Abstract] [Full Text] [Related]

  • 17. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
    Thomas MG, Ashworth LA, Miller E, Lambert HP.
    J Infect Dis; 1989 Nov 23; 160(5):838-45. PubMed ID: 2572651
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice.
    Jabbal-Gill I, Fisher AN, Rappuoli R, Davis SS, Illum L.
    Vaccine; 1998 Dec 23; 16(20):2039-46. PubMed ID: 9796062
    [Abstract] [Full Text] [Related]

  • 19. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
    Sato H, Sato Y.
    Dev Biol Stand; 1985 Dec 23; 61():461-7. PubMed ID: 2872127
    [Abstract] [Full Text] [Related]

  • 20. Mucosal and systemic immune responses elicited by recombinant Lactococcus lactis expressing a fusion protein composed of pertussis toxin and filamentous hemagglutinin from Bordetella pertussis.
    Torkashvand A, Bahrami F, Adib M, Ajdary S.
    Microb Pathog; 2018 Jul 23; 120():155-160. PubMed ID: 29738814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.